4.5 Article

Platelet-Derived Amyloid-β Protein Precursor as a Biomarker of Alzheimer's Disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cell Biology

Can platelet activation result in increased plasma Aβ levels and contribute to the pathogenesis of Alzheimer's disease?

Manuel Glauco Carbone et al.

Summary: Platelet activation is closely associated with the development of Alzheimer's disease and cerebrovascular diseases, and may be one of the pathophysiological mechanisms of AD. Intervening with platelet activation may represent a promising adjunct therapeutic approach for AD.

AGEING RESEARCH REVIEWS (2021)

Article Neurosciences

Identification of microRNA-9 linking the effects of childhood maltreatment on depression using amygdala connectivity

Cancan He et al.

Summary: Childhood maltreatment is considered a significant risk factor for major depressive disorder. This study investigated the neural basis of the effects of childhood maltreatment on depression, with a focus on microRNA-9. Higher miR-9 levels in MDD patients were associated with lower childhood maltreatment scores and less severe depressive symptoms, with overlapping effects on amygdala functional connectivity networks. The study also found that a support vector classifier model incorporating miR-9 levels, childhood maltreatment severity, and AFC strength could accurately differentiate MDD patients from healthy controls.

NEUROIMAGE (2021)

Review Biochemistry & Molecular Biology

Critical Molecular and Cellular Contributors to Tau Pathology

Liqing Song et al.

Summary: Tauopathies are neurodegenerative diseases characterized by the deposition of tau aggregates in the brain. The pathogenesis involves the formation of toxic tau seeds and transcellular propagation of pathogenic tau. Understanding the signaling pathways and cellular contributors is crucial for developing effective treatments.

BIOMEDICINES (2021)

Article Cell Biology

Platelet biomarkers for a descending cognitive function: A proteomic approach

Haitao Yu et al.

Summary: Memory loss is the most common clinical sign in Alzheimer's disease, and searching for peripheral biomarkers to predict cognitive decline is promising for early diagnosis. Platelets share similarities to neuron biology and may serve as a peripheral matrix for biomarkers of neurological disorders. The study identified 360 differential proteins in mild cognitive impairment and Alzheimer's disease patients, with potential for early screening of AD using a combination of decreased platelet proteins.

AGING CELL (2021)

Article Clinical Neurology

Dementia in China: epidemiology, clinical management, and research advances

Longfei Jia et al.

LANCET NEUROLOGY (2020)

Article Clinical Neurology

Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients

Jessyka Maria de Franca Bram et al.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2019)

Review Geriatrics & Gerontology

Decoding the Role of Platelets and Related MicroRNAs in Aging and Neurodegenerative Disorders

Yolanda Espinosa-Parrilla et al.

FRONTIERS IN AGING NEUROSCIENCE (2019)

Article Biochemistry & Molecular Biology

Blood-derived amyloid-beta protein induces Alzheimer's disease pathologies

X-L Bu et al.

MOLECULAR PSYCHIATRY (2018)

Article Clinical Neurology

The cost of Alzheimer's disease in China and re-estimation of costs worldwide

Jianping Jia et al.

ALZHEIMERS & DEMENTIA (2018)

Review Clinical Neurology

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

Clifford R. Jack et al.

ALZHEIMERS & DEMENTIA (2018)

Review Neurosciences

Platelets: Peripheral Biomarkers of Dementia?

Oluwatomi E. S. Akingbade et al.

JOURNAL OF ALZHEIMERS DISEASE (2018)

Article Neurosciences

Protein Expression of BACE1 is Downregulated by Donepezil in Alzheimer's Disease Platelets

Tamires Alves Sarno et al.

JOURNAL OF ALZHEIMERS DISEASE (2017)

Article Cardiac & Cardiovascular Systems

Brain Perivascular Macrophages Initiate the Neurovascular Dysfunction of Alzheimer Aβ Peptides

Laibaik Park et al.

CIRCULATION RESEARCH (2017)

Review Neurosciences

Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's disease

Ilaria Canobbio et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2015)

Review Clinical Neurology

Tau pathology and neurodegeneration

Maria Grazia Spillantini et al.

LANCET NEUROLOGY (2013)

Article Psychiatry

Platelet biomarkers in Alzheimer's disease

Leda L. Talib et al.

WORLD JOURNAL OF PSYCHIATRY (2012)

Article Neurosciences

Human Platelets Tau: A Potential Peripheral Marker for Alzheimer's Disease

Karen Neumann et al.

JOURNAL OF ALZHEIMERS DISEASE (2011)

Article Geriatrics & Gerontology

Blood cell markers in Alzheimer Disease: Amyloid Precursor Protein form ratio in platelets

Barbara Borroni et al.

EXPERIMENTAL GERONTOLOGY (2010)

Article Hematology

Proteomic analysis of platelet α-granules using mass spectrometry

D. M. Maynard et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)

Article Clinical Neurology

Platelet amyloid precursor protein processing: A bio-marker for Alzheimer's disease

K Tang et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)

Article Clinical Neurology

Predicting cognitive decline in Alzheimer disease - Role of platelet amyloid precursor protein

B Borroni et al.

ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2004)

Article Biochemistry & Molecular Biology

Amyloid precursor protein and amyloid β peptide in human platelets -: Role of cyclooxygenase and protein kinase C

DM Skovronsky et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)